AIDS and Cancer Specimen Bank (ACSB)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00587912 |
Recruitment Status
:
Completed
First Posted
: January 8, 2008
Last Update Posted
: April 21, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this study is to obtain clinical specimens from pathologists and physicians involved in the diagnosis and care of patients with AIDS and non-AIDS associated malignancies.
The National Cancer Institute has set up a Bank for tissues and biological fluids from HIVpositive and HIV-negative individuals in order to have specimens available for scientists studying malignancies associated with HIV disease.
Condition or disease |
---|
Kaposi's Sarcoma AIDS Related Kaposi's Sarcoma Classical Non-Hodgkin's Lymphoma HEMATOPOIETIC SYSTEM Cancer AIDS |
Study Type : | Observational |
Actual Enrollment : | 65 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | AIDS and Cancer Specimen Bank (ACSB) |
Study Start Date : | June 1997 |
Actual Primary Completion Date : | April 2011 |
Actual Study Completion Date : | April 2011 |

- Identify and improve access to tumor tissue, biological specimens, and associated clinical outcome data that could be utilized for research by the research community at-large on the pathogenesis of HIV and non-HIV associated malignancies. [ Time Frame: 3 years ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patient > 18 years of age
- Suspected or confirmed AIDS-Associated malignancy with or without HIV infection
- Will obtain fresh tissue and/or biological fluids
- Patient signed the correct version of the informed consent
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00587912
United States, New York | |
Memorial Sloan-Kettering Cancer Center | |
New York, New York, United States, 10065 |
Principal Investigator: | David Straus, MD | Memorial Sloan Kettering Cancer Center |
Additional Information:
Responsible Party: | David Straus, MD, Memorial Sloan-Kettering Cancer Center |
ClinicalTrials.gov Identifier: | NCT00587912 History of Changes |
Other Study ID Numbers: |
97-043 |
First Posted: | January 8, 2008 Key Record Dates |
Last Update Posted: | April 21, 2011 |
Last Verified: | April 2011 |
Keywords provided by Memorial Sloan Kettering Cancer Center:
Kaposi's Sarcoma AIDS Related Kaposi's Sarcoma Classical Non-Hodgkin's Lymphoma |
HEMATOPOIETIC SYSTEM Cancer AIDS |
Additional relevant MeSH terms:
Sarcoma Lymphoma, Non-Hodgkin Sarcoma, Kaposi AIDS-Related Opportunistic Infections Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms Lymphoma Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases |
Herpesviridae Infections DNA Virus Infections Virus Diseases Neoplasms, Vascular Tissue Opportunistic Infections Infection HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Parasitic Diseases Immunologic Deficiency Syndromes |